← Back to headlines
Semaglutide Patent Expiration Expected to Drastically Reduce Weight Loss Drug Prices
The patent protection for semaglutide, a popular active ingredient in weight loss medications, has expired this year, which is anticipated to lead to a significant drop in prices, making it more accessible to millions.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
